In clinical reality, the shortest feasible time frame to determine CRP kinetics, including flare-response for R/M HNSCC, is at 6 weeks since blood draws are usually performed at baseline and then once every 3 weeks shortly before ICIs are administrated. Here, CRP is linked to head and neck squamous cell carcinoma.